{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T23:50:52Z","timestamp":1788047452305,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012835","name":"Toho University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.taap.2025.117258","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T07:42:37Z","timestamp":1738654957000},"page":"117258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Nilotinib impairs relaxation and temporal electro-mechanical integrity in human iPS-derived cardiomyocyte sheets"],"prefix":"10.1016","volume":"496","author":[{"given":"Hiroko","family":"Izumi-Nakaseko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Sekino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Kambayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Himeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Okado-Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiko T.","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunari","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117258_bb0005","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/ijc.33119","article-title":"Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors","volume":"147","author":"Abu Rmilah","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.taap.2025.117258_bb0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.vascn.2016.12.003","article-title":"A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes","volume":"84","author":"Ando","year":"2017","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.taap.2025.117258_bb0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1113\/jphysiol.1994.sp020130","article-title":"Relaxation in rabbit and rat cardiac cells: species-dependent differences in cellular mechanisms","volume":"476","author":"Bassani","year":"1994","journal-title":"J. Physiol."},{"key":"10.1016\/j.taap.2025.117258_bb0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1085\/jgp.90.4.479","article-title":"Mechanisms contributing to the cardiac inotropic effect of Na pump inhibition and reduction of extracellular Na","volume":"90","author":"Bers","year":"1987","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.taap.2025.117258_bb0025","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3390\/cancers12040826","article-title":"Cardiovascular toxicity of tyrosine kinase inhibitors used in chronic myeloid leukemia: an analysis of the FDA adverse event reporting system database (FAERS)","volume":"12","author":"Cirmi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.taap.2025.117258_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejca.2018.08.016","article-title":"Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: a systematic review and network meta-analysis","volume":"104","author":"Fachi","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.taap.2025.117258_bb0035","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.yjmcc.2014.09.010","article-title":"Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: correlation and complementarity with extracellular electrophysiology","volume":"77","author":"Hayakawa","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.taap.2025.117258_bb0040","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1182\/blood-2012-04-423418","article-title":"Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase","volume":"121","author":"Hochhaus","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.taap.2025.117258_bb0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejphar.2014.06.064","article-title":"Effects of selective IKr channel blockade by E-4031 on ventricular electro-mechanical relationship in the halothane-anesthetized dogs","volume":"740","author":"Izumi-Nakaseko","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117258_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2131\/jts.42.183","article-title":"Characterization of human iPS cell-derived cardiomyocyte sheets as a model to detect drug-induced conduction disturbance","volume":"42","author":"Izumi-Nakaseko","year":"2017","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.taap.2025.117258_bb0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jphs.2018.07.011","article-title":"Application of human induced pluripotent stem cell-derived cardiomyocytes sheets with microelectrode array system to estimate antiarrhythmic properties of multi-ion channel blockers","volume":"137","author":"Izumi-Nakaseko","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.taap.2025.117258_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.542562","article-title":"Optimizing the direction and order of the motion unveiled the ability of conventional monolayers of human induced pluripotent stem cell-derived cardiomyocytes to show frequency-dependent enhancement of contraction and relaxation motion","volume":"8","author":"Izumi-Nakaseko","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.taap.2025.117258_bb0065","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1159\/000533325","article-title":"Evaluation of time to onset and outcome of cardiac adverse events associated with nilotinib using post-marketing surveillance","volume":"101","author":"Kanbayashi","year":"2023","journal-title":"Oncology"},{"key":"10.1016\/j.taap.2025.117258_bb0070","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1470-2045(11)70201-7","article-title":"Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial","volume":"12","author":"Kantarjian","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.taap.2025.117258_bb0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41375-020-01111-2","article-title":"Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis","volume":"35","author":"Kantarjian","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.taap.2025.117258_bb0080","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/srep02100","article-title":"MICE models: superior to the HERG model in predicting torsade de pointes","volume":"3","author":"Kramer","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2025.117258_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003623","article-title":"Suppression of phosphoinositide 3-kinase signaling and alteration of multiple ion currents in drug-induced long QT syndrome","volume":"4","author":"Lu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.taap.2025.117258_bb0090","doi-asserted-by":"crossref","first-page":"H2006","DOI":"10.1152\/ajpheart.00694.2011","article-title":"High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents","volume":"301","author":"Ma","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.taap.2025.117258_bb0095","series-title":"Full prescribing information for TASIGNA","author":"Novartis Pharmaceuticals Corporation","year":"2024"},{"key":"10.1016\/j.taap.2025.117258_bb0100","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2025.117258_bb0105","first-page":"C813","article-title":"Rat vs. rabbit ventricle: Ca flux and intracellular Na assessed by ion-selective microelectrodes","volume":"256","author":"Shattock","year":"1989","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.taap.2025.117258_bb0110","first-page":"4733","article-title":"Liposomes ameliorate Crizotinib- and Nilotinib-induced inhibition of the cardiac IKr channel and QTc prolongation","volume":"34","author":"Shopp","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.taap.2025.117258_bb0115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ctrv.2013.09.004","article-title":"Major molecular response during the first year of dasatinib, imatinib or nilotinib treatment for newly diagnosed chronic myeloid leukemia: a network meta-analysis","volume":"40","author":"Signorovitch","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.taap.2025.117258_bb0120","article-title":"Drug-induced long QT syndrome: concept and non-clinical models for predicting the onset of drug-induced torsade de pointes in patients in compliance with ICH E14\/S7B guidance","author":"Sugiyama","year":"2024","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2025.117258_bb0125","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1476-5381.2010.00934.x","article-title":"The electro-mechanical window: a risk marker for torsade de pointes in a canine model of drug induced arrhythmias","volume":"161","author":"van der Linde","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117258_bb0130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1476-5381.2010.00980.x","article-title":"A new preclinical biomarker for risk of torsades de pointes: drug-induced reduction of the cardiac electromechanical window","volume":"161","author":"Vargas","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117258_bb0135","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.RES.87.12.1103","article-title":"Ventricular fibrillation: how do we stop the waves from breaking?","volume":"87","author":"Weiss","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.taap.2025.117258_bb0140","series-title":"www.CredibleMeds.org, QTdrugs List, AZCERT, 1457 E. Desert Garden Dr., Tucson, AZ","author":"Woosley","year":"2024"},{"key":"10.1016\/j.taap.2025.117258_bb0145","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1248\/bpb.b22-00268","article-title":"Proarrhythmia risk assessment using electro-mechanical window in human iPS cell-derived cardiomyocytes","volume":"45","author":"Yanagida","year":"2022","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2025.117258_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100405","article-title":"Protocol for measurement of calcium dysregulation in human induced pluripotent stem cell-derived dopaminergic neurons","volume":"2","author":"Yin","year":"2021","journal-title":"STAR Protoc."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25000341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25000341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T10:44:27Z","timestamp":1740480267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"alternative-id":["S0041008X25000341"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117258","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nilotinib impairs relaxation and temporal electro-mechanical integrity in human iPS-derived cardiomyocyte sheets","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117258"}}